Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 4:11:e52045.
doi: 10.2196/52045.

Bayesian Networks for Prescreening in Depression: Algorithm Development and Validation

Affiliations

Bayesian Networks for Prescreening in Depression: Algorithm Development and Validation

Eduardo Maekawa et al. JMIR Ment Health. .

Abstract

Background: Identifying individuals with depressive symptomatology (DS) promptly and effectively is of paramount importance for providing timely treatment. Machine learning models have shown promise in this area; however, studies often fall short in demonstrating the practical benefits of using these models and fail to provide tangible real-world applications.

Objective: This study aims to establish a novel methodology for identifying individuals likely to exhibit DS, identify the most influential features in a more explainable way via probabilistic measures, and propose tools that can be used in real-world applications.

Methods: The study used 3 data sets: PROACTIVE, the Brazilian National Health Survey (Pesquisa Nacional de Saúde [PNS]) 2013, and PNS 2019, comprising sociodemographic and health-related features. A Bayesian network was used for feature selection. Selected features were then used to train machine learning models to predict DS, operationalized as a score of ≥10 on the 9-item Patient Health Questionnaire. The study also analyzed the impact of varying sensitivity rates on the reduction of screening interviews compared to a random approach.

Results: The methodology allows the users to make an informed trade-off among sensitivity, specificity, and a reduction in the number of interviews. At the thresholds of 0.444, 0.412, and 0.472, determined by maximizing the Youden index, the models achieved sensitivities of 0.717, 0.741, and 0.718, and specificities of 0.644, 0.737, and 0.766 for PROACTIVE, PNS 2013, and PNS 2019, respectively. The area under the receiver operating characteristic curve was 0.736, 0.801, and 0.809 for these 3 data sets, respectively. For the PROACTIVE data set, the most influential features identified were postural balance, shortness of breath, and how old people feel they are. In the PNS 2013 data set, the features were the ability to do usual activities, chest pain, sleep problems, and chronic back problems. The PNS 2019 data set shared 3 of the most influential features with the PNS 2013 data set. However, the difference was the replacement of chronic back problems with verbal abuse. It is important to note that the features contained in the PNS data sets differ from those found in the PROACTIVE data set. An empirical analysis demonstrated that using the proposed model led to a potential reduction in screening interviews of up to 52% while maintaining a sensitivity of 0.80.

Conclusions: This study developed a novel methodology for identifying individuals with DS, demonstrating the utility of using Bayesian networks to identify the most significant features. Moreover, this approach has the potential to substantially reduce the number of screening interviews while maintaining high sensitivity, thereby facilitating improved early identification and intervention strategies for individuals experiencing DS.

Keywords: AI; Bayesian network; anxiety; artificial intelligence; depression; depressive symptom; digital mental health; eHealth; mHealth; machine learning; machine learning model; mental health; mobile health; mood; mood disorder; mood disorders; patient; patient screening; prediction; prediction modeling; probabilistic machine learning; socioeconomic data sets; stochastic gradient descent; survey; target depressive symptomatology; telehealth; utilization.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure 1
Figure 1
Example of a random screening list. DS: depressive symptomatology; P(DS): probability of having depressive symptomatology.
Figure 2
Figure 2
Example of a ranked list provided by the models. Class=comparing predictions with observed values. DS: depressive symptomatology; FP: false positive; P(DS): probability of having depressive symptomatology; TN: true negative; TP: true positive.
Figure 3
Figure 3
Confusion matrix and area under the receiver operating characteristic curve for PROACTIVE. DS: depressive symptomatology; FN: false negative; FP: false positive; TN: true negative; TP: true positive.
Figure 4
Figure 4
Confusion matrix and area under the receiver operating characteristic curve for Pesquisa Nacional de Saúde 2013. DS: depressive symptomatology; FN: false negative; FP: false positive; TN: true negative; TP: true positive.
Figure 5
Figure 5
Confusion matrix and area under the receiver operating characteristic curve for Pesquisa Nacional de Saúde 2019. DS: depressive symptomatology; FN: false negative; FP: false positive; TN: true negative; TP: true positive.
Figure 6
Figure 6
PROACTIVE—trade-off between sensitivity versus reducing screening interviews. ROC: receiver operating characteristic.
Figure 7
Figure 7
Pesquisa Nacional de Saúde 2013—trade-off between sensitivity versus reducing screening interviews. ROC: receiver operating characteristic.
Figure 8
Figure 8
Pesquisa Nacional de Saúde 2019—trade-off between sensitivity versus reducing screening interviews. ROC: receiver operating characteristic.

Similar articles

Cited by

References

    1. Mitchell AJ, Vaze A, Rao S. Clinical diagnosis of depression in primary care: a meta-analysis. Lancet. 2009 Aug 22;374(9690):609–19. doi: 10.1016/S0140-6736(09)60879-5.S0140-6736(09)60879-5 - DOI - PubMed
    1. Lopes CS, Hellwig N, E Silva GA, Menezes PR. Inequities in access to depression treatment: results of the Brazilian National Health Survey - PNS. Int J Equity Health. 2016 Nov 17;15(1):154. doi: 10.1186/s12939-016-0446-1. https://equityhealthj.biomedcentral.com/articles/10.1186/s12939-016-0446-1 10.1186/s12939-016-0446-1 - DOI - DOI - PMC - PubMed
    1. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606–13. doi: 10.1046/j.1525-1497.2001.016009606.x. https://europepmc.org/abstract/MED/11556941 jgi01114 - DOI - PMC - PubMed
    1. Squires M, Tao X, Elangovan S, Gururajan R, Zhou X, Acharya UR, Li Y. Deep learning and machine learning in psychiatry: a survey of current progress in depression detection, diagnosis and treatment. Brain Inform. 2023 Apr 24;10(1):10. doi: 10.1186/s40708-023-00188-6. https://link.springer.com/article/10.1186/s40708-023-00188-6 10.1186/s40708-023-00188-6 - DOI - DOI - PMC - PubMed
    1. Zavlis O, Matheou A, Bentall R. Identifying the bridge between depression and mania: a machine learning and network approach to bipolar disorder. Bipolar Disord. 2023 Nov;25(7):571–82. doi: 10.1111/bdi.13316. https://eprints.whiterose.ac.uk/197501/ - DOI - PubMed

LinkOut - more resources